4.7 Meeting Abstract

Impact of 18F-fluciclovine PET/CT on Clinical Management of Patients with Recurrent Prostate Cancer: Results from the Phase 3 FALCON Trial

Journal

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ijrobp.2017.09.015

Keywords

-

Funding

  1. Blue Earth Diagnostics
  2. Leeds Teaching Hospitals Charitable Foundation
  3. Intercollegiate Standing Committee on Nuclear Medicine (Royal College of Physicians/Royal College of Radiologist, UK)
  4. Blue Earth Diagnostics, Siemens
  5. GE Healthcare
  6. Alliance Medical Ltd

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available